Interpace Biosciences
IDXG
#11365
Rank
N/A
Marketcap
N/A
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Interpace Biosciences (IDXG) - Total liabilities

Total liabilities on the balance sheet as of June 2026 : A$16.08 Million

According to Interpace Biosciences's latest financial reports the company's total liabilities are A$16.08 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Interpace Biosciences - Total liabilities on balance sheet (from 2001 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31A$17.13 M-37.34%
2024-12-31A$27.34 M-72.86%
2023-12-31A$0.10 B-13.25%
2022-12-31A$0.11 B4.17%
2021-12-31A$0.11 B14.69%
2020-12-31A$97.23 M128.08%
2019-12-31A$42.63 M91.52%
2018-12-31A$22.25 M26.58%
2017-12-31A$17.58 M-64.04%
2016-12-31A$48.89 M-34.85%
2015-12-31A$75.05 M-35.87%
2014-12-31A$0.11 B185.35%
2013-12-31A$41.01 M-0.45%
2012-12-31A$41.2 M-21.56%
2011-12-31A$52.52 M-2.77%
2010-12-31A$54.02 M39.11%
2009-12-31A$38.83 M-34.65%
2008-12-31A$59.43 M31.99%
2007-12-31A$45.02 M-32.31%
2006-12-31A$66.52 M-24.59%
2005-12-31A$88.21 M15.16%
2004-12-31A$76.6 M-29.82%
2003-12-31A$0.10 B-9.2%
2002-12-31A$0.12 B-59.57%
2001-12-31A$0.29 B